韩玲玉, 司南, 刘俊秋, 赵海誉, 杨健, 边宝林, 王宏洁. 华蟾素注射液中蟾毒配基类化学成分研究J. 药学学报, 2014,49(11): 1574-1577.
引用本文: 韩玲玉, 司南, 刘俊秋, 赵海誉, 杨健, 边宝林, 王宏洁. 华蟾素注射液中蟾毒配基类化学成分研究J. 药学学报, 2014,49(11): 1574-1577.
HAN Ling-yu, SI Nan, LIU Jun-qiu, ZHAO Hai-yu, YANG Jian, BIAN Bao-lin, WANG Hong-jie. Chemical constituents of bufadienolides in cinobufacino injectionJ. Acta Pharmaceutica Sinica, 2014,49(11): 1574-1577.
Citation: HAN Ling-yu, SI Nan, LIU Jun-qiu, ZHAO Hai-yu, YANG Jian, BIAN Bao-lin, WANG Hong-jie. Chemical constituents of bufadienolides in cinobufacino injectionJ. Acta Pharmaceutica Sinica, 2014,49(11): 1574-1577.

华蟾素注射液中蟾毒配基类化学成分研究

Chemical constituents of bufadienolides in cinobufacino injection

  • 摘要: 华蟾素注射液是中华大蟾蜍皮经精制加工制成的水溶性制剂, 临床应用广泛, 具有良好的抗肿瘤活性, 疗效较好, 蟾毒配基类化合物为其中抗肿瘤的主要活性成分。本研究针对华蟾素注射液中蟾毒配基类化合物进行了分离, 得到6个化合物, 分别鉴定结构为3-表-假蟾毒精(1)、假蟾毒精(2)、3-表-沙蟾毒精(3)、沙蟾毒精(4)、3-表-日蟾毒它灵(5)和3-氧代-沙蟾毒精(6)。其中13为新化合物, 56为新天然产物, 1234分别为两对C-3羟基构型异构体。

     

    Abstract: Cinobufacino injection is purified from water extraction of the skin of Bufo bufo gargarizans, which has been widely used for various cancers in clinic with significant anti-tumor effects. Bufadienolides were regarded as the main active constituents of cinobufacino injection in previous reports. In present study, 6 bufadienolides were isolated and purified from Cinobufacino injection. Their structures were identified as 3-epi-ψ-bufarenogin(1), ψ-bufarenogin(2), 3-epi-arenobufagin(3), arenobufagin(4), 3-epi-gamabufotalin(5), and 3-oxo-arenobufagin(6), separately. Among them, 1 and 3 were new compounds, 5 and 6 were new natural products. Compounds 1, 2 and compounds 3, 4 were two pairs configuration isomers at C-3, separately.

     

/

返回文章
返回